CStone Pharmaceuticals (2616.HK)

HKD 2.39

(-6.64%)

Gross Profit Summary of CStone Pharmaceuticals

CStone Pharmaceuticals's latest annual gross profit in 2023 was 304.29 Million CNY , up 9.31% from previous year.
CStone Pharmaceuticals's latest quarterly gross profit in 2024 Q1 was 86.01 Million CNY , up 14.03% from previous quarter.
CStone Pharmaceuticals reported a annual gross profit of 278.37 Million CNY in annual gross profit 2022, up 103.36% from previous year.
CStone Pharmaceuticals reported a annual gross profit of 136.88 Million CNY in annual gross profit 2021, down -82.83% from previous year.
CStone Pharmaceuticals reported a quarterly gross profit of 86.01 Million CNY for 2024 Q1, up 14.03% from previous quarter.
CStone Pharmaceuticals reported a quarterly gross profit of 304.29 Million CNY for 2023 FY, up 9.31% from previous quarter.

Annual Gross Profit Chart of CStone Pharmaceuticals (2023 - 2016)

Historical Annual Gross Profit of CStone Pharmaceuticals (2023 - 2016)

Year	Gross Profit	Gross Profit Growth
2023	304.29 Million CNY	9.31%
2022	278.37 Million CNY	103.36%
2021	136.88 Million CNY	-82.83%
2020	797.41 Million CNY	0.0%
2019	- CNY	-100.0%
2018	12.55 Million CNY	21.84%
2017	10.3 Million CNY	0.0%
2016	- CNY	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q2	86.01 Million CNY	0.0%
2024 Q1	86.01 Million CNY	14.03%
2023 FY	304.29 Million CNY	9.31%
2023 Q1	76.71 Million CNY	40.34%
2023 Q3	75.42 Million CNY	-1.68%
2023 Q2	76.71 Million CNY	0.0%
2023 Q4	75.42 Million CNY	0.0%
2022 Q4	54.66 Million CNY	0.0%
2022 FY	278.37 Million CNY	103.36%
2022 Q3	54.66 Million CNY	-35.32%
2022 Q2	84.52 Million CNY	0.0%
2022 Q1	84.52 Million CNY	90.68%
2021 Q4	44.32 Million CNY	0.0%
2021 Q3	44.32 Million CNY	83.8%
2021 FY	136.88 Million CNY	-82.83%
2021 Q1	24.11 Million CNY	-93.95%
2021 Q2	24.11 Million CNY	0.0%
2020 Q2	- CNY	0.0%
2020 Q3	398.7 Million CNY	0.0%
2020 FY	797.41 Million CNY	0.0%
2020 Q4	398.7 Million CNY	0.0%
2020 Q1	- CNY	100.0%
2019 Q3	-867 Thousand CNY	-200.0%
2019 FY	- CNY	-100.0%
2019 Q4	-867 Thousand CNY	0.0%
2019 Q1	867 Thousand CNY	-91.17%
2019 Q2	867 Thousand CNY	0.0%
2018 Q1	1.37 Million CNY	-86.66%
2018 FY	12.55 Million CNY	21.84%
2018 Q4	9.81 Million CNY	0.0%
2018 Q3	- CNY	-100.0%
2018 Q2	1.37 Million CNY	0.0%
2017 FY	10.3 Million CNY	0.0%
2017 Q4	10.3 Million CNY	0.0%
2016 FY	- CNY	0.0%

Peer Gross Profit Comparison of CStone Pharmaceuticals

Name	Gross Profit	Gross Profit Difference
Uni-Bio Science Group Limited	392.81 Million HKD	22.535%
CK Life Sciences Int'l., (Holdings) Inc.	947.7 Million HKD	67.891%